Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$12,032,682
+$2,960,991 QoQ
Shares Held
10,032
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#1,153
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. LLY ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,839 | $1,243,059 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,032,682 | 10,032 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $9,071,691 | 9,863 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $10,362,065 | 9,642 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,516,313 | 9,851 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $8,306,671 | 10,656 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $9,133,738 | 11,059 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,294,368 | 10,744 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,517,653 | 10,743 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $9,938,356 | 10,977 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $8,453,313 | 10,866 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $6,307,194 | 10,820 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,998,130 | 11,167 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,283,997 | 11,267 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,844,930 | 11,196 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,034,117 | 11,027 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,582,394 | 11,079 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,581,444 | 11,046 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,281,227 | 11,458 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,703,088 | 9,786 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,232,867 | 9,664 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,179,751 | 9,497 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,851,573 | 9,911 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,706,297 | 10,106 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,472,799 | 9,950 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,681,859 | 10,244 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,481,945 | 10,683 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||